Literature DB >> 5441411

Beta-adrenoceptive responses in the unanaesthetized ovine foetus.

G R Van Petten, R F Willes.   

Abstract

1. Isoprenaline injection into either the unanaesthetized ovine foetus or the pregnant ewe produced a transient tachycardia and hypotension in either the ewe or the foetus. No evidence was obtained for placental transfer, in either direction, of pharmacologically active isoprenaline.2. Propranolol, when given to the ewe intravenously, produced bradycardia and increased pulse pressure and inhibited the response of both the ewe and her foetus to isoprenaline. Propranolol, when given to the foetus intravenously, produced bradycardia and increased pulse pressure in both the foetus and the ewe, but only the foetal response to isoprenaline was inhibited. These data demonstrated that propranolol crossed the ovine placenta in both directions in a pharmacologically active form.3. Dose-heart rate curves of the foetus and pregnant ewe to isoprenaline and the shift to the right of the isoprenaline dose-response curves by propranolol were similar in both the ewe and the foetus.4. Notwithstanding the similarities between the ewe and foetus in their responses to isoprenaline or propranolol and in the antagonism of isoprenaline by propranolol, the duration of blockade following propranolol administration to the ewe was 2 to 3 times longer in the foetus compared with the ewe.5. Measurement of blood levels of propranolol showed that the maximum concentration of propranolol in foetal plasma was only 5% of that in the pregnant ewe when propranolol was infused into the ewe; the rate of clearance of propranolol was similar from the foetal and maternal plasma.6. From these data the long duration of beta-adrenoceptor blockade in the ovine foetus by propranolol cannot be fully explained. However, these data serve as examples of the dangers involved when extrapolating pharmacological actions of drugs on the foetus purely from data on foetal plasma levels of the drug.7. The data suggest that multiple doses of propranolol, given to maintain a beta-adrenoceptor blockade in the mother, could result in serious cumulative effects in the foetus.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5441411      PMCID: PMC1702568          DOI: 10.1111/j.1476-5381.1970.tb10598.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  9 in total

1.  EPINEPHRINE DERIVATES AND THE ACTIVITY OF THE HUMAN UTERUS. I. . THE INHIBITING EFFECT OF P-HYDROXYPHENYLISOPROPYLARTERENOL (CC-25) UPON UTERINE ACTIVITY IN HUMAN PREGNANCY.

Authors:  L STOLTE; T ESKES; J SEELEN; H D MOED; C VOGELSANG
Journal:  Am J Obstet Gynecol       Date:  1965-07-15       Impact factor: 8.661

2.  Insulin secretion by the ovine fetus in utero.

Authors:  R F Willes; J M Boda; J G Manns
Journal:  Endocrinology       Date:  1969-03       Impact factor: 4.736

3.  The treatment of endotoxin shock by beta adrenergic blockade.

Authors:  J L Berk; J F Hagen; W H Beyer; M J Gerber; G R Dochat
Journal:  Ann Surg       Date:  1969-01       Impact factor: 12.969

4.  The effect of blockade of the beta receptors of the sympathetic nervous system of the fetus. A preliminary report.

Authors:  I Joelsson; M D Barton
Journal:  Acta Obstet Gynecol Scand       Date:  1969       Impact factor: 3.636

5.  Effects of adrenergic blocking agents and catecholamines in human pregnancy.

Authors:  T P Barden; R W Stander
Journal:  Am J Obstet Gynecol       Date:  1968-09-15       Impact factor: 8.661

Review 6.  Beta-adrenergic receptor blocking drugs. Mechanisms of action and clinical applications.

Authors:  S E Epstein; E Braunwald
Journal:  N Engl J Med       Date:  1966-11-17       Impact factor: 91.245

Review 7.  Beta-adrenergic receptor blocking drugs. Mechanisms of action and clinical applications.

Authors:  S E Epstein; E Braunwald
Journal:  N Engl J Med       Date:  1966-11-24       Impact factor: 91.245

8.  Role of beta-adrenergic receptors in the circulatory response to hypoxia.

Authors:  H A Kontos; R R Lower
Journal:  Am J Physiol       Date:  1969-09

9.  EPINEPHRINE DERIVATES AND THE ACTIVITY OF THE HUMAN UTERUS. II. THE INFLUENCE OF PRONETHALOL AND PROPANOLOLT ON THE UTERINE AND SYSTEMIC ACTIVITY OF P-HYDROXYPHENYLISOPROPYLARTERENOL (CC-25).

Authors:  T ESKES; L STOLTE; J SEELEN; H D MOED; C VOGELSANG
Journal:  Am J Obstet Gynecol       Date:  1965-07-15       Impact factor: 8.661

  9 in total
  5 in total

1.  The in utero left ventricle of the fetal sheep: the effects of isoprenaline.

Authors:  P A Anderson; E C Fair; A P Killam; R Nassar; R D Mainwaring; R L Rosemond; L M Whyte
Journal:  J Physiol       Date:  1990-11       Impact factor: 5.182

2.  Hormone-initiated maturation of rat liver mitochondria after birth.

Authors:  R Sutton; J K Pollak
Journal:  Biochem J       Date:  1980-01-15       Impact factor: 3.857

3.  Pharmacokinetics of propranolol during pregnancy.

Authors:  M F O'Hare; C D Kinney; G A Murnaghan; D G McDevitt
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

4.  Action of several -adrenoceptor blocking drugs in the pregnant sheep and foetus.

Authors:  J F Truelove; G R van Petten; R F Willes
Journal:  Br J Pharmacol       Date:  1973-01       Impact factor: 8.739

5.  Randomised comparison of methyldopa and oxprenolol for treatment of hypertension in pregnancy.

Authors:  E D Gallery; D M Saunders; S N Hunyor; A Z Györy
Journal:  Br Med J       Date:  1979-06-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.